What is Humana Inc. share price today?

Humana Inc. (HUM) share price today is {{live_price}}.

Can Indians buy Humana Inc. shares?

Yes, Indians can invest in the Humana Inc. (HUM) from India. With INDmoney, you can buy Humana Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Humana Inc. at zero transaction cost.

How can I buy Humana Inc. shares from India?

It is very easy to buy Humana Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Humana Inc. be purchased?

Yes, you can buy fractional shares of Humana Inc. with INDmoney app.

What are the documents required to start investing in Humana Inc. stocks?

To start investing in Humana Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Humana Inc.

Today’s highest price of Humana Inc. (HUM) is {{1_rba_end}}. Today’s lowest price of Humana Inc. (HUM) is {{1_rba_st}}.

What is today's market capitalisation of Humana Inc.

Today's market capitalisation of Humana Inc. HUM is 32.2B

What is the 52 Week High and Low Range of Humana Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Humana Inc. is down from its 52 Week High?

Humana Inc. (HUM) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Humana Inc. is up from its 52 Week low?

Humana Inc. (HUM) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Humana Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Humana Inc.

Ms. Susan Marie Diamond is the current Chief Executive Officer (CEO) of Humana Inc..

Home>
US Stocks>
Humana Inc.

Humana Inc. (HUM)

$260.57

-6.57

(-2.46%)▲

Market is closed - opens 7 PM, 22 Oct 2024

Performance

$257.92
$275.13
$260.57
1.02%
Downside
Day's Volatility :6.26%
Upside
5.29%
$213.31
$527.18
$260.57
18.14%
Downside
52 Weeks Volatility :59.54%
Upside
50.57%

Returns

Period	Humana Inc.	Sector (Health Care)	S&P500
3 Months	-30.61%	3.6%	6.5%
6 Months	-17.88%	10.2%	18.1%
1 Year	-48.18%	19.6%	38.8%
3 Years	-42.03%	16.8%	28.9%

Highlights

Market Capitalization	32.2B
Book Value	$138.46
Dividend Share	3.54
Dividend Yield	1.33%
Earnings Per Share (EPS)	14.2
PE Ratio	18.81
PEG Ratio	1.07
Wall Street Target Price	294.01

Profit Margin	1.53%
Operating Margin TTM	4.09%

Return On Assets TTM	4.57%
Return On Equity TTM	10.16%

Revenue TTM	112.0B
Revenue Per Share TTM	919.63
Quarterly Revenue Growth YOY	10.4%
Gross Profit TTM	17.2B
EBITDA	4.3B
Diluted Eps TTM	14.2
Quarterly Earnings Growth YOY	-0.26

EPS Estimate Current Year	16.17
EPS Estimate Next Year	19.77
EPS Estimate Current Quarter	5.85
EPS Estimate Next Quarter	3.99

Analyst Recommendation

Buy

51%Buy

48%Hold

0%Sell

Based on 27 Wall street analysts offering stock ratings for Humana Inc.(by analysts ranked 0 to 5 stars)

Based on 27 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 12.83%

Current $260.57

Target $294.01

Company Financials

	FY18	Y/Y Change
Revenue	56.9B	↑ 5.85%
Net Income	1.7B	↓ 31.25%
Net Profit Margin	2.96%	↓ 1.59%

	FY19	Y/Y Change
Revenue	64.9B	↑ 14.01%
Net Income	2.7B	↑ 60.84%
Net Profit Margin	4.17%	↑ 1.21%

	FY20	Y/Y Change
Revenue	77.2B	↑ 18.9%
Net Income	3.4B	↑ 24.38%
Net Profit Margin	4.36%	↑ 0.19%

	FY21	Y/Y Change
Revenue	83.1B	↑ 7.66%
Net Income	2.9B	↓ 12.89%
Net Profit Margin	3.53%	↓ 0.83%

	FY22	Y/Y Change
Revenue	92.9B	↑ 11.81%
Net Income	2.8B	↓ 4.33%
Net Profit Margin	3.02%	↓ 0.51%

	FY23	Y/Y Change
Revenue	106.4B	↑ 14.54%
Net Income	2.5B	↓ 11.3%
Net Profit Margin	2.34%	↓ 0.68%

	Q1 FY23	Q/Q Change
Revenue	26.7B	↑ 19.18%
Net Income	1.2B	↓ 8360.0%
Net Profit Margin	4.63%	↑ 4.7%

	Q2 FY23	Q/Q Change
Revenue	26.7B	↑ 0.02%
Net Income	959.0M	↓ 22.6%
Net Profit Margin	3.59%	↓ 1.04%

	Q3 FY23	Q/Q Change
Revenue	26.4B	↓ 1.21%
Net Income	832.0M	↓ 13.24%
Net Profit Margin	3.15%	↓ 0.44%

	Q4 FY23	Q/Q Change
Revenue	26.5B	↑ 0.15%
Net Income	-541.0M	↓ 165.02%
Net Profit Margin	-2.04%	↓ 5.19%

	Q1 FY24	Q/Q Change
Revenue	29.6B	↑ 11.9%
Net Income	741.0M	↓ 236.97%
Net Profit Margin	2.5%	↑ 4.54%

	Q2 FY24	Q/Q Change
Revenue	29.5B	↓ 0.24%
Net Income	679.0M	↓ 8.37%
Net Profit Margin	2.3%	↓ 0.2%

	FY18	Y/Y Change
Total Assets	25.4B	↓ 6.49%
Total Liabilities	15.3B	↓ 12.02%

	FY19	Y/Y Change
Total Assets	29.1B	↑ 14.41%
Total Liabilities	17.0B	↑ 11.7%

	FY20	Y/Y Change
Total Assets	35.0B	↑ 20.28%
Total Liabilities	6.1B	↓ 64.43%

	FY21	Y/Y Change
Total Assets	44.4B	↑ 26.85%
Total Liabilities	10.5B	↑ 73.94%

	FY22	Y/Y Change
Total Assets	43.1B	↓ 2.94%
Total Liabilities	9.0B	↓ 14.3%

	FY23	Y/Y Change
Total Assets	47.1B	↑ 9.31%
Total Liabilities	10.2B	↑ 13.05%

	Q1 FY23	Q/Q Change
Total Assets	54.8B	↑ 27.22%
Total Liabilities	38.1B	↑ 37.77%

	Q2 FY23	Q/Q Change
Total Assets	56.5B	↑ 3.07%
Total Liabilities	39.6B	↑ 3.73%

	Q3 FY23	Q/Q Change
Total Assets	55.9B	↓ 0.97%
Total Liabilities	9.5B	↓ 76.03%

	Q4 FY23	Q/Q Change
Total Assets	47.1B	↓ 15.81%
Total Liabilities	10.2B	↑ 7.7%

	Q1 FY24	Q/Q Change
Total Assets	50.1B	↑ 6.43%
Total Liabilities	12.4B	↑ 21.32%

	Q2 FY24	Q/Q Change
Total Assets	50.1B	↑ 0.0%
Total Liabilities	11.7B	↓ 5.2%

	FY18	Y/Y Change
Operating Cash Flow	2.2B	↓ 46.36%
Investing Cash Flow	-3.1B	↑ 4.96%
Financing Cash Flow	-785.0M	↓ 16.93%

	FY19	Y/Y Change
Operating Cash Flow	5.3B	↑ 143.17%
Investing Cash Flow	-1.3B	↓ 58.6%
Financing Cash Flow	-2.3B	↑ 192.36%

	FY20	Y/Y Change
Operating Cash Flow	5.6B	↑ 6.72%
Investing Cash Flow	-3.1B	↑ 139.83%
Financing Cash Flow	-2.0B	↓ 14.81%

	FY21	Y/Y Change
Operating Cash Flow	2.3B	↓ 59.89%
Investing Cash Flow	-6.6B	↑ 113.9%
Financing Cash Flow	3.0B	↓ 254.22%

	FY22	Y/Y Change
Operating Cash Flow	4.6B	↑ 102.79%
Investing Cash Flow	-1.0B	↓ 84.66%
Financing Cash Flow	-1.9B	↓ 163.48%

	Q1 FY23	Q/Q Change
Operating Cash Flow	6.7B	↓ 230.43%
Investing Cash Flow	-1.3B	↑ 28.43%
Financing Cash Flow	3.3B	↓ 239.06%

	Q2 FY23	Q/Q Change
Operating Cash Flow	3.2B	↓ 52.5%
Investing Cash Flow	-733.0M	↓ 43.27%
Financing Cash Flow	36.0M	↓ 98.9%

	Q3 FY23	Q/Q Change
Operating Cash Flow	1.3B	↓ 60.58%
Investing Cash Flow	-2.6B	↑ 256.07%
Financing Cash Flow	-1.7B	↓ 4913.89%

Technicals Summary

Sell

Neutral

Buy

Humana Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Humana Inc.	-14.59%	-17.88%	-48.18%	-42.03%	-6.97%
The Cigna Corp	-5.34%	-4.86%	11.61%	55.39%	101.51%
Centene Corp.	-17.69%	-17.94%	-12.48%	-10.1%	35.5%
Unitedhealth Group Incorporated	-0.66%	15.96%	9.21%	28.79%	133.52%
Cvs Health Corporation	4.81%	-13.34%	-12.54%	-30.53%	-8.16%
Elevance Health, Inc	-19.32%	-19.06%	-4.65%	0.08%	70.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Humana Inc.	18.81	18.81	1.07	16.17	0.1	0.05	0.01	138.46
The Cigna Corp	27.89	27.89	0.78	28.5	0.09	0.03	0.02	147.88
Centene Corp.	11.68	11.68	0.59	6.82	0.11	0.04	NA	52.0
Unitedhealth Group Incorporated	36.83	36.83	1.49	27.62	0.15	0.07	0.01	107.4
Cvs Health Corporation	11.33	11.33	2.09	6.53	0.1	0.03	0.04	59.66
Elevance Health, Inc	15.55	15.55	0.73	36.67	0.17	0.06	0.01	168.64

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Humana Inc.	Buy	$32.2B	-6.97%	18.81	1.53%
The Cigna Corp	Buy	$98.7B	101.51%	27.89	1.72%
Centene Corp.	Buy	$32.6B	35.5%	11.68	1.96%
Unitedhealth Group Incorporated	Buy	$522.7B	133.52%	36.83	3.64%
Cvs Health Corporation	Buy	$80.1B	-8.16%	11.33	1.99%
Elevance Health, Inc	Buy	$103.0B	70.22%	15.55	3.9%

Insights on Humana Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 29.61B → 29.54B (in $), with an average decrease of 0.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 741.0M → 679.0M (in $), with an average decrease of 8.4% per quarter
Vs CI
In the last 1 year, The Cigna Corp has given 9.5% return, outperforming this stock by 58.2%
Vs CI
In the last 3 years, The Cigna Corp has given 55.4% return, outperforming this stock by 97.4%

Institutional Holdings

Vanguard Group Inc
9.13%
BlackRock Inc
9.12%
State Street Corp
4.41%
Wellington Management Company LLP
3.82%
Dodge & Cox
3.58%
Eagle Capital Management LLC
2.68%

Corporate Announcements

Humana Inc. Dividends March,2024
In the quarter ending March,2024. Humana Inc. has declared dividend of $0.89
Read More

Organization	Humana Inc.
Employees	65000
CEO	Ms. Susan Marie Diamond
Industry	Health Services

Humana Inc. (HUM)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Decreasing Revenue

Decreasing Net Profit

Vs CI

Vs CI

Institutional Holdings

Corporate Announcements

Humana Inc. Dividends March,2024

Company Information

Discover More

FAQs